Vista Pharmaceuticals Ltd. - Research Center
524711 VISTAPH Group (Z) BSE data
Results
|
Quarterly
|
Statement
|
|
More
|
|
Quarterly results in brief
(Rs crore)
|
Jun' 24 |
Mar' 24 |
Dec' 23 |
Sep' 23 |
Jun' 23 |
Sales |
1.80 |
3.13 |
1.70 |
3.47 |
1.98 |
Operating profit |
-0.78 |
0.26 |
-1.74 |
-1.17 |
-0.92 |
Interest |
0.28 |
0.28 |
0.30 |
0.32 |
0.33 |
Gross profit |
-0.99 |
0.08 |
-2.02 |
-1.41 |
-1.12 |
EPS (Rs) |
-0.14 |
0.02 |
-0.35 |
-0.46 |
-0.21 |
Quarterly
results in details
|
Jun' 24 |
Mar' 24 |
Dec' 23 |
Sep' 23 |
Jun' 23 |
Other income |
0.07 |
0.10 |
0.02 |
0.08 |
0.13 |
Stock adjustment |
- |
0.01 |
- |
0.09 |
-0.09 |
Raw material |
1.60 |
1.49 |
2.21 |
3.11 |
2.06 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
0.45 |
0.48 |
0.45 |
0.45 |
0.42 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
0.52 |
0.89 |
0.78 |
0.99 |
0.52 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
0.18 |
0.18 |
0.18 |
0.18 |
0.17 |
Taxation |
-0.31 |
-0.19 |
-0.57 |
0.43 |
-0.33 |
Net profit / loss |
-0.86 |
0.09 |
-1.63 |
-2.02 |
-0.95 |
Extra ordinary item |
- |
- |
- |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
12.31 |
9.43 |
9.38 |
8.84 |
9.06 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
-43.27 |
8.38 |
-102.37 |
-33.66 |
-46.49 |
GPM (%) |
-52.95 |
2.54 |
-116.73 |
-39.62 |
-52.79 |
NPM (%) |
-45.92 |
2.81 |
-94.23 |
-56.89 |
-45.17 |